All entries for: Small Molecule

May 9, 2023

IDEAYA Biosciences

Negative Outlook

San Francisco, CA
51-200 employees
51-200 employees
Disease Area: Oncology
Drug Type: Small Molecule
May 9, 2023

Exelixis

Negative Outlook

Alameda, CA
1,001-5,000 employees
1001-5000 employees
Disease Area: Oncology
Drug Type: Small Molecule
May 8, 2023

Recursion Pharmaceuticals

Neutral Outlook

Salt Lake City, UT
201-500 employees
201-500 employees
Disease Area: Multiple, Oncology
Drug Type: Biologic, Small Molecule
May 5, 2023

Merck

Negative Outlook

Rahway, NJ
50,001+ employees
50001+ employees
Disease Area: Oncology
Drug Type: Biologic, Small Molecule
May 5, 2023

Atea Pharmaceuticals

Negative Outlook

Boston, MA
51-200 employees
51-200 employees
Disease Area: Antiviral
Drug Type: Small Molecule
May 4, 2023

Regeneron

Neutral Outlook

Tarrytown, NY
10,001-50,000 employees
10001-50000 employees
Disease Area: Multiple
Drug Type: Biologic, Small Molecule
May 3, 2023

Gilead

Negative Outlook

Foster City, CA
10,001-50,000 employees
10001-50000 employees
Disease Area: Antiviral
Drug Type: Biologic, Small Molecule
May 3, 2023

Cerevel Therapeutics

Negative Outlook

Cambridge, MA
201-500 employees
201-500 employees
Disease Area: Neurological Diseases
Drug Type: Small Molecule
April 27, 2023

Bristol Myers Squibb

Negative Outlook

Princeton, NJ
10,001-50,000 employees
10001-50000 employees
Drug Type: Biologic, Small Molecule
April 26, 2023

Alkermes

Negative Outlook

Dublin, Ireland
1,001-5,000 employees
1001-5000 employees
Disease Area: Oncology
Drug Type: Small Molecule
Scroll to Top